UNSPSC 51273909: Benzocaine/boric acid

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class DE700. This VA Drug Class (DE700) classifies this compound as belonging to the group LOCAL ANESTHETICS, TOPICAL.

UNSPSC 51273909 Benzocaine/boric acid is a Commodity code that in recent state and local procurement activity encompasses a broader range of pharmaceutical and over-the-counter products than its nominal title suggests. State and local governments soliciting under this code are purchasing generic multi-source pharmaceuticals, naloxone and drug deactivation systems, and OTC products through competitive bidding processes and cooperative purchasing vehicles. Issuing bodies include county health departments, state health and human services commissions, and multistate cooperative purchasing alliances that aggregate demand across participating state and local jurisdictions. The work involves fulfilling ongoing annual or multi-year supply contracts with quarterly or routine deliveries to designated health facilities, clinics, and distribution centers, with vendors responsible for logistics, compliance with pharmaceutical regulatory standards including current Good Manufacturing Practices and Drug Supply Chain Security Act certification, and maintenance of contractual relationships with authorized wholesalers where required.

Recent activity spans Florida, Texas, and Minnesota. Seminole County, Florida issued IFB 60459723LAS in June 2026 seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building, with a response deadline of July 26, 2023. The Texas Health and Human Services Commission posted RFI HHS0017013 in April 2026 to gather vendor intelligence on implementing direct-to-manufacturer prescription programs outside traditional pharmacy benefit manager and group purchasing organization channels. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration, issued RFP S1070000015802 in January 2026 for generic multi-source pharmaceuticals and OTC products to be supplied through three authorized wholesalers with an effective date of July 1, 2026; proposals were due March 26, 2026, with awards weighted 75 percent on price competitiveness and the remainder on pricing format compliance, EDI capability, and administrative requirements.